Background Osteogenesis imperfecta (OI) is a rare heritable connective tissue disorder
primarily characterised by skeletal deformity and fragility, and an array of secondary …

Medication-related osteonecrosis of the jaw (MRONJ) is defined by the American
Association of Oral and Maxillofacial Surgeons (AAOMS) as the presence of an exposed …

Abstract Background Bisphosphonates (BPs) contrast the bone fragility and improve bone
density in some metastatic cancers and bone diseases, such as Osteogenesis Imperfecta …

Osteogenesis imperfecta (OI) is a rare genetic disorder characterized by fragile bones and
skeletal deformities. Individuals with OI may have dental abnormalities such as …

Currently, over 500 rare genetic bone disorders are identified. These diseases are often
accompanied by dental abnormalities, which are sometimes the first clue for an early …

Purpose Osteogenesis imperfecta (OI) results from mutations in the genes involved in the
modification or biosynthesis of collagen. This study aimed to assess the oral health-related …

Objective To evaluate whether individuals with osteogenesis imperfecta (OI) are more
affected by malocclusion than individuals without OI. Materials and Methods Searches in …

Background Osteogenesis imperfecta (OI) is the most common inherited disorder of bone
fragility in children, increasing fracture risk 100-fold and can feature dental and facial bone …

This chapter describes and discuss the oral problems faced by children, adolescents and
young adults with disabilities. Oral problems in this group of patients are more pronounced …

The aim of the study was to verify the viability of the correction of malocclusion in individuals
with osteogenesis imperfecta (OI). A systematic review was developed using PubMed, Web …